4.7 Review

MicroRNA profiling in cancer

期刊

CLINICAL SCIENCE
卷 121, 期 3-4, 页码 141-158

出版社

PORTLAND PRESS LTD
DOI: 10.1042/CS20110005

关键词

cancer; gene expression profile; leukaemia; malignancy; microRNA; non-coding RNA

资金

  1. University of Texas MD Anderson Research Trust
  2. CLL Global Research Foundation
  3. National Institutes of Health (including MD Anderson's Cancer Center) [CA016672]
  4. Department of Defense
  5. Seena Magowitz - Pancreatic Cancer Action Network
  6. Louisiana State University

向作者/读者索取更多资源

The diagnosis of cancer has undergone major changes in the last 40 years. Once based purely on morphology, diagnosis has come to incorporate immunological, cytogenetic and molecular methods. Many cancers, especially leukaemias, are now defined by molecular markers. Gene expression profiling based on mRNA has led to further refinement of the classification and diagnosis of cancer. More recently, miRNAs (microRNAs), among other small non-coding RNA molecules, have been discovered and found to be major players in cell biology. miRNAs, having both oncogenic and tumour-suppressive functions, are dysregulated in many types of cancer. miRNAs also interfere with metastasis, apoptosis and invasiveness of cancer cells. In the present review, we discuss recent advances in miRNA profiling in human cancer. We discuss both frequent and rare tumour types and give an outlook on future developments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据